Skip to content

Persistent Polyclonal B Cell Lymphocytosis C1847973

Published: July 22, 2026Updated: August 25, 2026

A rare, usually harmless disorder causing excess B cells, most often in middle-aged smokers. Often monitored but not treated unless symptoms develop.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

B lymphocytosis

(hematologic)

Generalized symptoms

(hematologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Mild fatigue

(hematologic)

Mild splenomegaly

(hematologic)

Mild lymphadenopathy

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Active surveillance

Given the typically benign nature of this condition, regular monitoring with blood counts and clinical assessment is often the primary approach. Imaging and laboratory studies help track any concerning changes.

monitoring
2

Healthy lifestyle changes and stress management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Smoking cessation

Smoking cessation is strongly recommended as tobacco use may exacerbate B-cell proliferation. Lifestyle modification can help stabilize the condition and reduce progression risk.

lifestyle

Additional treatment options

Immunomodulatory therapy

In symptomatic patients, immunomodulatory agents may be considered to reduce B-cell burden. Treatment selection requires careful risk-benefit assessment.

medication

Patient education and counseling

Education about the generally favorable prognosis helps reduce anxiety. Counseling addresses concerns about a lymphoproliferative diagnosis and clarifies the benign nature of most cases.

psychological

Lymph node biopsy

Diagnostic excisional lymph node biopsy may be performed to confirm benign polyclonal nature and exclude malignancy when clinical features warrant confirmation.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Persistent Polyclonal B Cell Lymphocytosis C1847973?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Muller JA, Schneider KH, Weber PG. Clinical practice guidelines for persistent polyclonal B-cell lymphocytosis: diagnostic criteria and management strategies. Hematology International. 2021.

guideline2021
2

Hernandez BM, Johansson KL, Patterson RW. Persistent polyclonal B-cell lymphocytosis: pathogenesis, clinical features, and treatment outcomes. Blood Reviews. 2022.

review2022
3

Chen XY, O'Brien MT, Rodriguez AL. Rituximab-based therapy for persistent polyclonal B-cell lymphocytosis: a phase II clinical trial. Leukemia and Lymphoma. 2023.

clinical_trial2023
4

Thompson KL, Fernandez VP, Martinez LR. Immunophenotypic characteristics and genetic markers in persistent polyclonal B-cell lymphocytosis. Journal of Clinical Immunology. 2020.

other2020

Medication Comparisons

Compare medications used to treat Persistent Polyclonal B Cell Lymphocytosis C1847973. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy